Home/Pipeline/Digital Therapeutic Platform for Lung Disease

Digital Therapeutic Platform for Lung Disease

Lung Disease (e.g., COPD, Asthma, ILD)

Pre-clinicalActive

Key Facts

Indication
Lung Disease (e.g., COPD, Asthma, ILD)
Phase
Pre-clinical
Status
Active
Company

About Apreo Health

Apreo Health is a private, early-stage digital health company targeting the significant unmet needs in lung disease management. Operating in a pre-revenue, investigational stage, the company is developing a medical device platform currently limited to clinical investigations under U.S. regulatory law. Its mission centers on creating patient-centric, transformative solutions to improve respiratory health outcomes, positioning it in the high-growth digital therapeutics and remote monitoring landscape for chronic pulmonary conditions.

View full company profile